US Futures rise - Watch GS, UNH, BK, MRNA

,

The S&P 500 Futures remain on the upside on Covid-19 vaccine hopes

Uptrend 4

The S&P 500 Futures remain on the upside on Covid-19 vaccine hopes.

Later today, the U.S. Labor Department will release June import price index (+1.0% on month expected). The New York Federal Reserve will publish July Empire Manufacturing Index (10.0 expected). The Federal Reserve will release its Beige Book, June industrial production (+4.4% on month expected) and capacity utilization (67.8% expected). 

European indices stay in the green. The U.K. Office for National Statistics has released June CPI at +0.6% (vs +0.4% on year expected). Also, EU General Court has annulled the decision taken by the EU Commission regarding the Irish Tax Rulings over EUR 13 billion in favor of Apple.

Asian indices closed in the green except the Chinese CSI. The Bank of Japan held its benchmark rate at -0.10%, as expected.

WTI Crude Oil futures are posting a rebound. OPEC technical committee suggested that countries including Iraq, Nigeria and Kazakhstan should make an additional 842K b/d of compensatory cuts in August and September, reported Bloomberg citing delegates. Meanwhile, the American Petroleum Institute (API) reported that U.S. crude stockpiles dropped 8.32M bbl for the week ended July 10 (-2.28M bbl expected). Later today, the Energy Information Administration (EIA) will release official crude oil inventories data for the same week (-0.88M bbl expected)
WTI Crude Oil futures remain on the downside after reports that major oil-producing countries may ease output curbs in view of improving demand.

Gold gained 3.03 dollars (+0.17%) to 1812.39 dollars.


USD remains under pressure on hopes of a Covid-19 vaccine.

EUR/USD rose 34pips to 1.1434 the day's range was 1.1391 - 1.1445 compared to 1.1325 - 1.1409 the previous session.


U.S. Equity Snapshot

Goldman Sachs (GS), a global investment firm, reported second quarter EPS of 6.26 dollars, above estimates, from 5.81 dollars a year earlier. Net revenue advanced 41% to 13.3 billion dollars, beating estimates.

Source: TradingView, Gain Capital


UnitedHealth (UNH), a private health insurance provider, disclosed second quarter adjusted EPS up to 7.12 dollars, above estimates, from 3.60 dollars a year earlier. The company still expects full year adjusted EPS of 16.25-16.55 dollars.

Bank of New York Mellon (BK), an international financial company, reported second quarter EPS of 1.01 dollar, stable compared to last year but above estimates. Net interest margin decreased to 0.88% from 1.12% a year earlier.

U.S. Bancorp (USB), a diversified financial services firm, announced second quarter adjusted EPS of 0.41 dollar, beating estimates. Net interest margin decreased to 2.62% from 3.13% a year earlier.

Moderna (MRNA), a biotechnology company, announced that its mRNA COVID-19 vaccine was able to produce antibodies to the coronavirus in all patients in a phase 1 study and a phase 3 trial is expected to begin on July 27.


More from Equities

Disclaimer: GAIN Capital UK Limited (trading as "Forex.com") is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, Forex.com does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.

No opinion given in this material constitutes a recommendation by Forex.com or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although Forex.com is not specifically prevented from dealing before providing this material, Forex.com does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

For further details see our full non-independent research disclaimer and quarterly summary.